Working Out M0 Bipolar Androgen Therapy
NCT06594926
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Testosterone Enanthate
Sponsor
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Collaborators
[object Object]
[object Object]
[object Object]